Works matching IS 15460096 AND DT 2024 AND VI 21 AND IP 1

The 4^th NextGen therapies for SJIA and MAS: part 3 clinical trials in refractory SJIA: historic controls as an alternative to a withdrawal design study.

Published in:

Pediatric Rheumatology, 2024, v. 21, n. 1, p. 1, doi. 10.1186/s12969-023-00866-z

By:

• de Benedetti, Fabrizio;
• Grom, Alexei A.;
• Brunner, Hermine

Publication type:

Article